23 diciembre 2014
A new combination of two different approaches — virotherapy and immunotherapy — is showing ‘great promise’ as a treatment for pancreatic cancer, according to new research. The study investigated whether the effectiveness of the Vaccinia oncolytic virus — a virus modified to selectively infect and kill cancer cells — as a treatment for pancreatic cancer, would be improved by arming it with a gene which modulates the body’s immune system.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/3YfTxmSG-TU/141223114022.htm
